An inherited genetic tendency appears to increase the likelihood that a person can successfully fight off antibiotic-resistant staph infections, according to a study led by Duke Health researchers.
A potential carcinogen that has been banned as a food additive is present in concerningly high levels in electronic cigarette liquids and smokeless tobacco products, according to a new study from Duke Health.
In small, community hospitals that don’t have resources for a dedicated staff to oversee the proper use of antibiotics, turning to staff pharmacists showed promise in a model study conducted by Duke Health.
Children afflicted with medical emergencies during commercial airline trips tend to have common ailments such as vomiting, fever or allergic reactions – events that should be easily treated, according to a study led by Duke Health researchers.
Scientists studying poison ivy rashes in mice have identified two proteins and a neurotransmitter involved in poison ivy itch in mice. They could be potential drug targets that could lead to treating the aggravating itch in people.
Efforts by the FDA and some cities to limit the availability and appeal of e-cigarettes to young users could drive some existing users to smoke more tobacco cigarettes to get their fix, according to new research from Duke Health.
Duke researchers describe a previously unidentified route for antibodies to be transferred from the mother to the fetus, illuminating a potential way to capitalize on this process to control when and how certain antibodies are shared.
Aging adults often show signs of slowing when it comes to managing their finances, such as calculating their change when paying cash or balancing an account ledger. But trouble managing money can also be a harbinger of dementia and, according to new Du…
Doctors often cite the high price of a prescription drug as a reason they don’t prescribe it, while patients similarly say that cost is a main reason they quit taking a drug.
Removing this financial barrier might increase the use of evidence-based t…
A research team at the Duke Cancer Institute has found a new way to keep the immune system engaged, and is planning to test the approach in a phase 1 clinical trial.